Project Grant K99CA304501
Award Date
7/14/25
Completion Date
6/30/27
Dollars Obligated
$130K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Vermont, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $130,501 to The Salk Institute for Biological Studies to conduct research on the role of muscle CDKN1A in cancer cachexia. The key objectives are to: 1) elucidate the function of muscle CDKN1A in muscle dysfunction during cancer cachexia, 2) define the temporal regulation of CDKN1A by BCL6 in response to nutrient availability, and 3) assess immune modulation of muscle CDKN1A as a...
This Project Grant award of $1,396,152.00 from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) aims to examine the role of the protein BNIP3 and mitophagy (selective degradation of mitochondria) in muscle atrophy during cancer cachexia associated with pancreatic ductal adenocarcinoma (PDAC). The research will utilize genetically engineered mouse models of PDAC to investigate how BNIP3 promotes atrophy of muscle fibers by reducing mitochondrial mass, and how reconstitution...
This Project Grant award of $147,486 from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) supports research at the University of Pittsburgh to investigate the role of altered lipid metabolism in CD8 T cell exhaustion within the tumor microenvironment. The project aims to (1) evaluate the impact of abolishing citrate transport on carbon utilization and effector function of CD8 T cells in the tumor environment, and (2) determine the role of stored lipids in CD8 T cell...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $441,913 to Tufts University School of Medicine to leverage existing DNA methylation data to better understand the biological pathways linking obesity and increased risk of 13 obesity-related cancers. The research aims to identify specific adiposity-related DNA methylation markers associated with these obesity-related cancers, explore their underlying gene ontology, and...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $160,330 to the University of Illinois to develop novel lung adenocarcinoma models that better capture the initiation, progression, and composition of primary human lung tumors. The researchers aim to introduce oncogenic mutations into primary human lung stem and progenitor cells, and then culture them as tumor organoids or xenograft them into immunodeficient mice. This work seeks to...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $247,660 to Weill Medical College of Cornell University to conduct research comparing the outcomes of different fat grafting techniques for breast reconstruction after mastectomy. The project will utilize fat samples from an ongoing randomized controlled trial to assess volume retention and the cellular microenvironment of fat grafts processed using three different techniques:...
This Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $432,889 to The Johns Hopkins University to conduct research aimed at advancing cancer screening, diagnostic technologies, and early detection methodologies. The project, titled "Molecular Imaging and Metabolotheranostics of PDAC-Induced Cachexia", will focus on reversing cachexia (severe muscle wasting) induced by pancreatic ductal adenocarcinoma...
The National Cancer Institute (NCI) awarded a $512,974 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the Sloan-Kettering Institute for Cancer Research, a non-profit cancer research institution located in New York City. The grant, effective August 13, 2024 through July 31, 2029, will fund research to develop advanced predictive models for non-small cell lung cancer (NSCLC) outcomes using a combination of real-world data sources, including tumor genomic...
This Cooperative Agreement award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides funding of $179,988 to the University of Utah to conduct research on the role of dietary lipids in accelerating breast cancer tumor growth, particularly in the context of obesity. The key objectives are to: Determine if breast cancer cells preferentially utilize dietary lipids over glucose in lipid-rich environments, such as those found in obesity. Trace the metabolic fate of...
This $369,868 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research to investigate the functional role of mitochondrial transfer from nerves to breast cancer cells, and how this process impacts cancer metastasis and the generation of cancer stem cells. The project aims to use innovative lineage-tracing techniques to quantify the contribution of nerve-to-cancer mitochondrial transfer to the breast cancer metastasis cascade, and evaluate...